NMTC
NeuroOne Medical Technologies Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.75
-0.04 ▼ -4.73%
🌙 3월 13일 5:59 PM ET (한국 3/14 06:59)
$0.77
+0.02 ▲ +3.04%
| Index | - | P/E | - | EPS (ttm) | -0.16 | Insider Own | 6.67% | Shs Outstand | 0.05B | Perf Week | -10.86% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 32.43% | Insider Trans | 41.18% | Shs Float | 0.05B | Perf Month | -8.39% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.04 | Inst Own | 32.85% | Short Float | 0.23% | Perf Quarter | 25.2% |
| Income | -0.01B | P/S | 4.37 | EPS this Y | -37.04% | Inst Trans | -4.49% | Short Ratio | 0.36 | Perf Half Y | -16% |
| Sales | 0.01B | P/B | 5.92 | EPS next 5Y | 61.84% | ROA | -90.61% | Short Interest | 0.11M | Perf YTD | -0.9% |
| Book/sh | 0.13 | P/C | 10.7 | EPS past 3/5Y | 47.62% 48.66% | ROE | -146.27% | 52W High | -35.24% ($1.16) | Perf Year | -26.35% |
| Cash/sh | 0.07 | P/FCF | - | Sales past 3/5Y | 78.7% 44.41% | ROIC | -104.86% | 52W Low | 89.98% ($0.40) | Perf 3Y | -49.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.93% | Gross Margin | 54.87% | Volatility(W/M) | 7.36% 9.4% | Perf 5Y | -90.38% |
| Dividend TTM | - | EV/Sales | 3.99 | Sales Y/Y TTM | -0.38% | Oper. Margin | -87.71% | ATR (14) | 0.07 | Perf 10Y | -54.47% |
| Dividend Ex-Date | - | Quick Ratio | 5.07 | EPS Q/Q | -149.48% | Profit Margin | -78.34% | RSI (14) | 47.23 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.39 | Sales Q/Q | -53.9% | SMA20 | 1.23% ($0.74) | Beta | 0.61 | Target Price | $2.03 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/02/17 | SMA50 | -7.46% ($0.81) | Rel Volume | 0.26 | Prev Close | $0.79 |
| Employees | 18 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 25% 8.93% | SMA200 | -3.12% ($0.77) | Avg Volume(3M) | 0.30M | Price | $0.75 |
| IPO | 2013/6/27 | Option/Short | Yes/Yes | Trades | 200 | Volume | 75,771 | Change | -4.73% |
뉴스 로딩 중...